Mahkam Zanganeh insider trades

Open-market stock purchases and sales by Mahkam Zanganeh, Co-Chief Executive Officer at Summit Therapeutics Inc, from SEC Form 4 filings since Dec 6, 2022.

Track record: 67% of 9 scored buys are up 5% or more since purchase, averaging +118%.

Recent trades

DateStockTradeValue
Jun 12, 2026SMMT Summit Therapeutics IncBought$50M
Jun 11, 2026PLSE Pulse Biosciences, IncBought (not open market)—
Jun 11, 2026PLSE Pulse Biosciences, IncBought (not open market)—
Jun 4, 2026SMMT Summit Therapeutics IncBought$1.5M
Jan 2, 2026SMMT Summit Therapeutics IncBought (not open market)$98.4K
Oct 21, 2025SMMT Summit Therapeutics IncBought (not open market)$5M
Oct 21, 2025SMMT Summit Therapeutics IncBought$500K
Oct 21, 2025SMMT Summit Therapeutics IncBought (not open market)$262M

Companies traded

  • SMMT Summit Therapeutics Inc: 15 buys, last Jun 12, 2026
  • PLSE Pulse Biosciences, Inc: 1 buy, last Jun 11, 2026

Get free alerts when Mahkam Zanganeh files a new trade →